Advertisement

The Patient pp 143-175 | Cite as

Psychosis

  • Hoyle Leigh
  • Morton F. Reiser

Keywords

Antipsychotic Drug Schizophrenic Patient Organize Crime Auditory Hallucination Borderline Personality Disorder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

Recommended Reading

  1. Bowers MB Jr: Retreat from Sanity-The Structure of Emerging Psychosis New York, Human Sciences Press, 1974.Google Scholar
  2. Leigh H, Kramer SI: The psychiatric manifestations of endocrine disease. Adv Intern Med 29: 413–445, 1984.PubMedGoogle Scholar
  3. Lidz T, Fleck S, Cornelison AR: Schizophrenia and the Family. New York, International Universities Press, 1965.Google Scholar
  4. Stevens JR: An anatomy of schizophrenia? Arch Gen Psychiatry 29: 177–189, 1973.PubMedCrossRefGoogle Scholar
  5. Strauss JS, Carpenter WT Jr: Schizophrenia. New York, Plenum Press, 1981.Google Scholar

References

  1. Amkraut AP, Solomon GF, Allansmith M, et al.: Immuno-globulins and improvement in acute schizophrenic reactions. Arch Gen Psychiatry 28: 673–677, 1973.PubMedCrossRefGoogle Scholar
  2. Andreasen NC, Olsen, S: Negative vs. positive schizophrenia. Arch Gen Psychiatry 39: 789794, 1982.Google Scholar
  3. Andreasen NC, Olsen SA, Dennert JW, et al.: Ventricular enlargement in schizophrenia: Relationship to positive and negative symptoms. Am J Psychiatry 139: 297–302, 1982.PubMedGoogle Scholar
  4. Bartholini G, Da Prada M, Pletscher A: Decrease of cerebral 5-hydroxytryptamine by 3,4dihydroxyphenylalanine after inhibition of extracerebral decarboxylase. J Pharm Pharmacol 20: 228–229, 1968.PubMedCrossRefGoogle Scholar
  5. Bateson G, Jackson D, Haley J, et al.: Towards a theory of schizophrenia. Behav Sci 1: 25 1264, 1956.Google Scholar
  6. Berrettini WH, Benfield TC, Schmidt AO, et al.: Platelet monoamine oxidase in families of chronic schizophrenics. Schizophrenia Bull 6: 235–237, 1980.Google Scholar
  7. Bowers MB Jr: Acute psychosis induced by psychotomimetic drug abuse: Neurochemical findings. Arch Gen Psychiatry 27: 440–442, 1972.PubMedCrossRefGoogle Scholar
  8. Bowers MB Jr: Retreat from Sanity-The Structure of Emerging Psychosis New York, Human Sciences Press, 1974.Google Scholar
  9. Bowers MB Jr: Biochemical processes in schizophrenia: An update. NIMH Special Report, Schizophrenia, 1980, pp 27–34.Google Scholar
  10. Bowers MB Jr: Evaluation and management of psychosis, in Leigh H (ed): Psychiatry in the Practice of Medicine. Menlo Park, California, Addison-Wesley Publishing Co, 1983, pp 103–112.Google Scholar
  11. Bowers MB Jr, Freedman DX: Psychedelic experiences in acute psychosis. Arch Gen Psychiatry 125: 240–248, 1966.CrossRefGoogle Scholar
  12. Brown GW, Birley JLT, Wing JK: Influence of family life on the course of schizophrenic disorders: A replication. Br J Psychiatry 121: 241–258, 1972.PubMedCrossRefGoogle Scholar
  13. Buchsbaum MS, Ingvar DH, Kessler R, et al.: Cerebral glucography with positron tomography: Use in normal subjects and in patients with schizophrenia. Arch Gen Psychiatry 39: 251–259, 1982.PubMedCrossRefGoogle Scholar
  14. Burch PRJ, Rowell NR, Burwell RG: Schizophrenia: Auto-immune or auto-aggressive? Br Med J 2: 50, 1968.CrossRefGoogle Scholar
  15. Chapman LI: Recent advances in the study of schizophrenic cognition. Schizophrenia Bull 5: 568–580, 1979.Google Scholar
  16. Creese I, Snyder SH: Increased brain dopamine and dopamine receptors in schizophrenia. Arch Gen Psychiatry 39: 991–997, 1982.PubMedCrossRefGoogle Scholar
  17. Crow TJ: Molecular pathology of schizophrenia: More than one disease process? Br Med J 280: 66–68, 1980.PubMedCrossRefGoogle Scholar
  18. Crow TI, Ferrier IN, Johnstone EC, et al.: Characteristics of patients with schizophrenia or neurological disorder and virus-like agent in cerebrospinal fluid. Lancet 1:842–844, 1979.Google Scholar
  19. Faris REL, Dunham HW: Mental Disorders in Urban Areas. Chicago, University of Chicago Press, 1939.Google Scholar
  20. Flor-Henry P: Lateralized temporal–limbic dysfunction and psychopathology. Ann NY Acad Sci 280: 777–795, 1976.PubMedCrossRefGoogle Scholar
  21. Freud S: The Interpretation of Dreams, Strachey J (ed). New York, Avon Books, 1965 (originally published, 1900 ).Google Scholar
  22. Fromm-Reichmann F: Notes on the development of treatment of schizophrenia by psychoanalytic psychotherapy. Psychiatry 11: 263–273, 1948.PubMedGoogle Scholar
  23. Gelenberg AJ: The catatonic syndrome. Lancet 1: 1339–1341, 1976.PubMedCrossRefGoogle Scholar
  24. Gottesman II, Shields J: A critical review of recent adoption, twin, and family studies of schizophrenia: Behavioral genetics perspectives. Schizophrenia Bull 2: 360–401, 1976.Google Scholar
  25. Haracz IL: The dopamine hypothesis: An overview of studies with schizophrenic patients. Schizophrenia Bull 8: 438–469, 1982.Google Scholar
  26. Hirata-Hibi M, Higashi S, Tachibana T, et al.: Stimulated lymphocytes in schizophrenia. Arch Gen Psychiatry 39: 82–87, 1982.PubMedCrossRefGoogle Scholar
  27. Hollingshead AB, Redlich FC: Social Class and Mental Illness. New York, Wiley, 1958.CrossRefGoogle Scholar
  28. Holzman PS, Proctor LR, Levy DL, et al.: Eye tracking dysfunctions in schizophrenic patients and their relatives. Arch Gen Psychiatry 31:143–151, 1974.Google Scholar
  29. Horrobin DF: Schizophrenia as a prostaglandin deficiency disease. Lancet 1: 936–937, 1977.PubMedCrossRefGoogle Scholar
  30. Jefferson JW, Marshall JR: Neuropsychiatric Features of Medical Disorders. New York, Plenum Press, 1981.Google Scholar
  31. Kafka MS, Van Kammen DP, Bunney WE: Reduced cyclic AMP production in the blood platelets from schizophrenic patients. Am J Psychiatry 136: 685–687, 1979.PubMedGoogle Scholar
  32. Kety SS, Rosenthal D, Wender PH, et al.: The types and prevalence of mental illness in the biological and adoptive families of adopted schizophrenics, in Rosenthal D, Ketty SS (eds): The Transmission of Schizophrenia. Oxford, Pergamon Press, 1968, pp 345–362.Google Scholar
  33. Kramer M: Population changes and schizophrenia, 1970–1985, in Wynne LC, Cromwell RL, Matthysse S (eds): The Nature of Schizophrenia: New Approaches to Research and Treatment. New York, Wiley, 1978, pp 545–571.Google Scholar
  34. Landau SG, Buchsbaum MS, Carpenter WT, et al.: Schizophrenia and stimulus intensity control. Arch Gen Psychiatry 32: 1239–1245, 1975.PubMedCrossRefGoogle Scholar
  35. Lee T, Seeman P: Dopamine receptors in normal and schizophrenic human brains. Soc Neurosci Abstr 3: 443, 1977.Google Scholar
  36. Lee T, Seeman P: Elevation of brain neuroleptic/dopamine receptors in schizophrenia. Am J Psychiatry 137: 191–197, 1980.PubMedGoogle Scholar
  37. Leigh H: Schizophrenia, in Leigh H (ed): Psychiatry in the Practice of Medicine. Menlo Park, California, Addison-Wesley Publishing Co, 1983, pp 113–121.Google Scholar
  38. Leigh H, Kramer SI: The psychiatric manifestations of endocrine disease. Adv Intern Med 29: 413–445, 1984.PubMedGoogle Scholar
  39. Lidz T, Fleck S, Cornelison AR: Schizophrenia and the Family. New York, International Universities Press, 1965.Google Scholar
  40. Luchins DJ, Weinberger DR, Wyatt RJ: Schizophrenia. Arch Gen Psychiatry 36: 1309–1311, 1979.PubMedCrossRefGoogle Scholar
  41. Mackay AVP, Doble A, Bird E, et al.: 3H-Spiperone binding in normal and schizophrenic postmortem human brain. Life Sci 23:527–532, 1978.Google Scholar
  42. Meltzer HI: Neuromuscular dysfunction in schizophrenia. Schizophrenia Bull 2: 106–146, 1976.Google Scholar
  43. Morel BA: Traite des Maladies Mentales. Paris, Victor Masson, 1860.Google Scholar
  44. Osmond H, Smythies J: Schizophrenia: A new approach. J Ment Sci 98: 309–315, 1952.PubMedGoogle Scholar
  45. Quitkin F, Rifkin A, Klein DF: Neurologic soft signs in schizophrenia and character disorders. Arch Gen Psychiatry 33: 845–853, 1976.PubMedCrossRefGoogle Scholar
  46. Rosengarten H, Friedhoff AJ: A review of recent studies of the biosynthesis and excretion of hallucinogens formed by methylation of neurotransmitters or related substances. Schizophrenia Bull 2: 90–105, 1976.Google Scholar
  47. Rosenhan DL: On being sane in insane places. Science 197: 250–252, 1973.CrossRefGoogle Scholar
  48. Rosenthal D: The heredity-environment issue in schizophrenia: Summary of the constant and present status of our knowledge, in Rosenthal D, Kety SS (eds): The Transmission of Schizophrenia. London, Pergamon Press, 1968, p 413.Google Scholar
  49. Schneider K: Clinical Psychopathology, New York, Grune and Stratton, 1959.Google Scholar
  50. Seeman P, Ulpian C, Bergeron C, et al.: Bimodal distribution of dopamine receptor densities in brains of schizophrenics. Science 225: 728–731, 1984.PubMedCrossRefGoogle Scholar
  51. Siever LJ, Haier RJ, Coursey RD, et al.: Smooth pursuit eye tracking impairment. Arch Gen Psychiatry 39: 1001–1005, 1982.PubMedCrossRefGoogle Scholar
  52. Snyder, SH: Madness and the Brain. New York, McGraw-Hill, 1974.Google Scholar
  53. Stevens JR: An anatomy of schizophrenia? Arch Gen Psychiatry 29: 177–189, 1973.PubMedCrossRefGoogle Scholar
  54. Strauss JS, Carpenter WT Jr: Schizophrenia. New York, Plenum Press, 1981.Google Scholar
  55. Strauss JS, Kokes RF, Klorman R, et al.: Premorbid adjustment in schizophrenia: Concepts, measures, and implications. Schizophrenia Bull 3 (2): 182–244, 1977.Google Scholar
  56. Tsuang MT, Woolson RF: Excess mortality in schizophrenia and affective disorders: Do suicides and accidental deaths solely account for this excess? Arch Gen Psychiatry 35: 1181–1185, 1978.PubMedCrossRefGoogle Scholar
  57. Tyrrell DAJ, Parry RP, Crow TJ, et al.: Possible virus in schizophrenia and some neurological disorders. Lancet 1: 839–841, 1979.PubMedCrossRefGoogle Scholar
  58. Vaughn CE, Leff JP: The influence of family and social factors on the course of psychiatric illness: A comparison of schizophrenic and depressed neurotic patients. Br J Psychiatry 129: 125–137, 1976.PubMedCrossRefGoogle Scholar
  59. Wyatt RJ, Potkin SG, Bridge TP et al.: Monoamine oxidase in schizophrenia: An overview. Schizophrenia Bull 6:199–207, 1980.Google Scholar
  60. Wynne L, Rickoff I, Day J, et al.: Pseudomutuality in the family relations of schizophrenics. Psychiatry 21:205–220, 1958.PubMedGoogle Scholar
  61. Wynne LC, Singer MT, Barko J, et al.: Schizophrenics and their families: recent research on parental communication, In Tanner JM (ed): Developments in Psychiatric Research. London, Hodder and Stoughton, 1977, pp 254–286.Google Scholar

Copyright information

© Hoyle Leigh and Morton F. Reiser 1985

Authors and Affiliations

  • Hoyle Leigh
    • 1
    • 2
  • Morton F. Reiser
    • 3
  1. 1.Yale University School of MedicineYale-New Haven HospitalNew HavenUSA
  2. 2.Psychiatric Consultation-Liaison and Outpatient ServicesYale-New Haven HospitalNew HavenUSA
  3. 3.Department of PsychiatryYale University School of MedicineNew HavenUSA

Personalised recommendations